Park, P.S.U.; Raynor, W.Y.; Sun, Y.; Werner, T.J.; Rajapakse, C.S.; Alavi, A.
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications. Int. J. Mol. Sci. 2021, 22, 6504.
https://doi.org/10.3390/ijms22126504
AMA Style
Park PSU, Raynor WY, Sun Y, Werner TJ, Rajapakse CS, Alavi A.
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications. International Journal of Molecular Sciences. 2021; 22(12):6504.
https://doi.org/10.3390/ijms22126504
Chicago/Turabian Style
Park, Peter Sang Uk, William Y. Raynor, Yusha Sun, Thomas J. Werner, Chamith S. Rajapakse, and Abass Alavi.
2021. "18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications" International Journal of Molecular Sciences 22, no. 12: 6504.
https://doi.org/10.3390/ijms22126504
APA Style
Park, P. S. U., Raynor, W. Y., Sun, Y., Werner, T. J., Rajapakse, C. S., & Alavi, A.
(2021). 18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications. International Journal of Molecular Sciences, 22(12), 6504.
https://doi.org/10.3390/ijms22126504
